Advances in epigenetic modifications and cervical cancer research

被引:17
作者
Liu, Hui [1 ]
Ma, Huimin [1 ]
Li, Yang [1 ,3 ]
Zhao, Hua [2 ,3 ]
机构
[1] Zhengzhou Univ, Henan Prov Peoples Hosp, Peoples Hosp, Dept Hlth Management Ctr, Zhengzhou 450003, Henan, Peoples R China
[2] Zhengzhou Univ, Henan Reprod Hosp, Henan Prov Peoples Hosp, Peoples Hosp, Zhengzhou 450003, Henan, Peoples R China
[3] Henan Prov Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2023年 / 1878卷 / 03期
基金
中国国家自然科学基金;
关键词
Epigenetic modification; DNA methylation; Histone modification; Noncoding RNA regulation; Molecular marker; LONG NONCODING RNA; COMPETING ENDOGENOUS RNA; SUPPRESSES TUMOR-GROWTH; CELL-PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; REGULATES PROLIFERATION; PROMOTES TUMORIGENESIS; PROGRESSION; METASTASIS;
D O I
10.1016/j.bbcan.2023.188894
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cervical cancer (CC) is an important public health problem for women, and perspectives and information regarding its prevention and treatment are quickly evolving. Human papilloma virus (HPV) has been recognized as a major contributor to CC development; however, HPV infection is not the only cause of CC. Epigenetics refers to changes in gene expression levels caused by non-gene sequence changes. Growing evidence suggests that the disruption of gene expression patterns which were governed by epigenetic modifications can result in cancer, autoimmune diseases, and various other maladies. This article mainly reviews the current research status of epigenetic modifications in CC based on four aspects, respectively DNA methylation, histone modification, noncoding RNA regulation and chromatin regulation, and we also discuss their functions and molecular mechanisms in the occurrence and progression of CC. This review provides new ideas for early screening, risk assessment, molecular targeted therapy and prognostic prediction of CC.
引用
收藏
页数:15
相关论文
共 232 条
  • [11] Cancer of the cervix uteri
    Bermudez, Adriana
    Bhatla, Neerja
    Leung, Eric
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2015, 131 : S88 - S95
  • [12] Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer
    Beyer, Susanne
    Zhu, Junyan
    Mayr, Doris
    Kuhn, Christina
    Schulze, Sandra
    Hofmann, Simone
    Dannecker, Christian
    Jeschke, Udo
    Kost, Bernd P.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03)
  • [13] Long Noncoding RNA and Cancer: A New Paradigm
    Bhan, Arunoday
    Soleimani, Milad
    Mandal, Subhrangsu S.
    [J]. CANCER RESEARCH, 2017, 77 (15) : 3965 - 3981
  • [14] Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer
    Bhat, Samatha
    Kabekkodu, Shama Prasada
    Noronha, Ashish
    Satyamoorthy, Kapaettu
    [J]. BIOCHIMIE, 2016, 121 : 298 - 311
  • [15] Chromatin structure regulation in transforming growth factor-β-directed epithelial-mesenchymal transition
    Blumenberg, Miroslav
    Gao, Shujuan
    Dickman, Kathleen
    Grollman, Arthur P.
    Bottinger, Erwin P.
    Zavadil, Jiri
    [J]. CELLS TISSUES ORGANS, 2007, 185 (1-3) : 162 - 174
  • [16] pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant
    Brunner, A.
    Riss, P.
    Heinze, G.
    Brustmann, H.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 107 (01) : 84 - 90
  • [17] Septin9 DNA methylation as a promising biomarker for cervical cancer
    Bu, Qiaowen
    Luo, Xiping
    He, Lulu
    Ma, Jian
    He, Shaoyi
    Lei, Wen
    Zhou, Weiping
    Deng, Hua
    Lin, Yu
    Zhang, Liang
    Hong, Xiaoshan
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 43 (01)
  • [18] LncRNA HOTAIR enhances RCC2 to accelerate cervical cancer progression by sponging miR-331-3p
    Buranjiang, Gulimire
    Abuduwanke, Ailikemu
    Li, Xiaowen
    Abulizi, Guzalinuer
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (06) : 1650 - 1660
  • [19] Cervical cancer therapies: Current challenges and future perspectives
    Burmeister, Carly A.
    Khan, Saif F.
    Schafer, Georgia
    Mbatani, Nomonde
    Adams, Tracey
    Moodley, Jennifer
    Prince, Sharon
    [J]. TUMOUR VIRUS RESEARCH, 2022, 13
  • [20] LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway
    Cai, Yi-Pin
    Huang, Yu
    Zhang, Jie
    Liu, Xiao-Li
    Zhao, Fang
    Zhang, Kuan
    Yang, Yan
    Huang, Hai -Wei
    Gao, Yu
    [J]. NEOPLASMA, 2022, 69 (06) : 1406 - +